Science Simplified!

Comment

Comment by Dr. Krishna Kumari Challa on Tuesday

The researchers then tested the effect in mice by disabling the FNIP1 pathway in the liver. Even when fed a high-fat, high-sugar junk-food diet for up to 30 weeks, these mice were strongly protected against weight gain and fat buildup in the liver.

The results identify FNIP1 as a key player in how the human body manages energy and metabolic biomarkers. Researchers are hopeful that blocking it therapeutically could eventually be used to tackle heart disease, obesity and diabetes.

George Hindy et al, FNIP1 variants are associated with favourable metabolism in 1 million humans, Nature (2026). DOI: 10.1038/s41586-026-10864-2

Part 2

Comment by Dr. Krishna Kumari Challa on Tuesday

People carrying a rare gene variant have naturally low body fat, healthier livers and better blood sugar levels

There are people around us who can maintain their weight despite what they eat. This has led scientists to believe that a person's metabolism and tendency toward obesity may have genetic factors behind them. A large study sequencing the genomes of more than 1 million people across three continents, found genetic clues that could drive this tendency. The findings are published in Nature.
They used exome sequencing to identify the specific parts of DNA responsible for building proteins, looking for rare gene variants and their associations with the ratio of triglycerides to HDL cholesterol (TG) in the blood (TG: HDL), a marker linked to several heart and metabolic risk factors and diseases.

They pinpointed 59 genes associated with this marker that help regulate how the body balances, stores and burns energy. One of the major players is the FNIP1 (folliculin-interacting protein 1) gene, which essentially acts as a brake on energy expenditure, stopping cells from burning too much energy.

About 1 in 7,000 people carry a rare, naturally occurring genetic mutation that switches off one copy of the FNIP1 gene. This anomaly appeared to come with its share of metabolic advantages, including significant protection against obesity and liver fat, a more favourable distribution of body fat and around 60% lower odds of cardiometabolic disease, among others.
In this study, the researchers built a massive data set that allowed them to identify meaningful patterns in genetic variants associated with healthier metabolism. The team collected genetic data and health records from 1,032,116 people across 11 study groups spanning North America, Europe and Asia.

To read the participants' DNA, they focused specifically on the exome, the 1% of our DNA that contains the instructions for making proteins. Then they looked at TG: HDL in their blood and matched those results with advanced diagnostic data. Using a powerful software program called REGENIE, they searched for genetic variants associated with higher or lower TG: HDL.

The study showed that a simple blood measurement like the TG: HDL ratio, which is the ratio of triglycerides to HDL, the "good" cholesterol, can act as a highly accurate indicator of full-body metabolic health. A higher TG: HDL ratio was strongly associated with excess body fat, dangerous fat buildup around vital organs, insulin resistance and higher blood pressure.

Fifty-nine independent genes were found to directly shape how the body balances energy, stores fat and manages metabolism. Nearly all of them operate in the liver and fat tissue, the body's core metabolic hubs. Of these, 23 genes—close to 40%—already had drugs targeting them, either approved or being tested in clinical trials.

They found that carriers of the rare FNIP1 gene variant had a very healthy metabolic profile. Compared with noncarriers, they showed lower levels of blood fats, including triglycerides and bad cholesterol; lower body weight and body-fat percentage; and a healthier distribution of body fat. They also had lower blood sugar and significantly less fat stored in the liver.
Part 1

Comment by Dr. Krishna Kumari Challa on Tuesday

A baby's lungs may begin responding to vitamin D sooner than once thought
Many pregnant women around the world are low in vitamin D. This is a very common issue that has prompted inquiries over the years. It is believed that low levels in pregnant women can cause harm to foetal development. Currently, scientists are asking a controversial question. What if the key time for vitamin D effects is before a woman knows that she's pregnant? By week 16 of pregnancy, the structural makeup of their developing airways—that is, the blueprint of breathing—is complete.
This timing begs an interesting question. According to a recent review published in Nutrients, it is not the amount of the nutrient that is important. Rather, it is the timing of the availability of vitamin D.

In short, this is the most important factor that would help us understand childhood asthma. New research suggests that there should be more focus on supplementation during the initial weeks, even before conception. The bulk of the early lung development generally occurs by the time clinical trials first start taking place.
All earlier vitamin D studies were conducted after conception, never before.
A 2025 Cochrane review affirms this trend. The research found that giving a high dose of vitamin D during pregnancy probably protects against wheezing in childhood, though it probably makes "little to no difference" to doctor-diagnosed asthma. Giving more vitamin D to pregnant women lowered wheezing in toddlers on average but did not convincingly prevent an asthma diagnosis.

Notably, these studies pointed out that all these trials started quite late and usually measured vitamin D only once. The researchers say that these designs yield only "weak evidence against the periconceptional hypothesis because they were not designed to test it."
The main takeaway is this: taking vitamin D before pregnancy might matter more than taking huge doses afterwards.

In the early weeks, when the fundamental branches of the lungs are established, it is likely that vitamin D benefits airway programming the most.

The review noted that none of the large trials, in fact, tested giving vitamin D pre-conception or in the first trimester. If timing matters, starting the supplements after 20 weeks may have been too late. The researchers argue that focusing on a higher dose in late pregnancy won't uncover an asthma-prevention effect if it was needed earlier.

Looking to the future, the researchers call for new trials that begin several weeks before conception and continue through early pregnancy. They also suggest measuring vitamin D repeatedly (not just once) and following children longer, with objective lung tests. Such studies could identify if a "vitamin D vacuum" in early pregnancy leaves lungs more vulnerable to asthma.

Oana Raluca Temneanu et al, Timing over Dose: Maternal Vitamin D, Periconceptional Window, and Early-Life Respiratory Programming, Nutrients (2026). DOI: 10.3390/nu18142333

Comment by Dr. Krishna Kumari Challa on August 9, 2026 at 9:39am

Brain turns listening inward during REM sleep, EEG recordings suggest
Across wakefulness to phasic REM sleep, EEG responses to external sounds progressively decreased, while responses to heartbeats were preserved or strengthened in 25 participants. This indicates a selective shift from external to internal sensory processing rather than global sensory suppression. An audio–cardiac response index may help characterize altered consciousness.

Sensory processing reallocation from auditory to cardiac signals in REM sleep, Current Biology (2026). DOI: 10.1016/j.cub.2026.07.024

Comment by Dr. Krishna Kumari Challa on August 9, 2026 at 9:01am

How to keep the Earth habitable when the sun dies

In a billion years, the sun will start to run out of fuel and expand to become a red giant. Earth's oceans and atmosphere will be burned away, and Earth will likely be engulfed by the sun altogether. The sun will then shrink to a dim white dwarf, and all light and warmth in the solar system will diminish. In a hundred trillion years, the galaxy's ability to produce stars will be exhausted, and everything will turn dark. However, there's a way for life to escape this fate—and what's more, we wouldn't need to leave the planet to do it. We just need to build some safeguards.

A proposed long-term strategy uses a sunshade, artificial fusion power from gas giants, and orbital adjustment to protect Earth during solar evolution. Antimatter-driven core heating could sustain tectonics, while directed mass beams could alter Solar System motion. The concept remains highly speculative and requires extreme resources.

Gabriel Harry, Retaining Earth's Habitability Beyond the Life of the Sun, Journal of the British Interplanetary Society (2026). DOI: 10.59332/jbis-079-07-0230. On arXiv: DOI: 10.48550/arxiv.2607.13084.

Comment by Dr. Krishna Kumari Challa on August 8, 2026 at 12:20pm

Brain activity reveals two stages of visual processing before conscious perception
EEG decoding indicated early occipital activity (~200 ms) encoding individual visual offsets and their temporal order without conscious separation. Later central-parietal activity (~450 ms) represented the integrated percept and behavioural reports, consistent with sequential unconscious encoding followed by conscious visual integration.

Maëlan Q. Menétrey et al, Sequential neural dynamics underlie unconscious integration and conscious perception of visual stimuli, PLOS Biology (2026). DOI: 10.1371/journal.pbio.3003894

Comment by Dr. Krishna Kumari Challa on August 8, 2026 at 12:02pm

Meta says its AI model hacked another company, adding to worries about bots going rogue
A Meta AI model gained unintended internet access during cybersecurity testing and exploited a third-party vulnerability; the incident is under investigation. Related tests reported unsanctioned online actions by AI agents under reduced safeguards, highlighting containment needs for cyber-capability evaluations.
source: News agencies

Comment by Dr. Krishna Kumari Challa on August 8, 2026 at 10:24am

Conversely, when the researchers blocked the SETD7 enzyme from adding too much of the H3K4me1 tag after early-life stress, the slinky remained closed, shielding mice from becoming hypersensitive to stress later in life. Despite experiencing both early-life and adult stress, mice with their SETD7 levels dampened were able to remain as social and exploratory as unstressed mice, and their dopamine neurons were active at normal levels.

There are currently no treatments for what early-life stress does to the brain, partially because we have not had a clear picture of what molecular mechanisms to target.
This work is exciting because it reveals a clear mechanism and also helps explain why the impact of stress is both latent and broad. Additionally, if we can step in with supportive care, therapy or social resources to buffer children during those sensitive windows of development, we may be able to protect the epigenome—preventing the genetic slinky from locking into an open position and perhaps giving the developing brain a chance to build natural resilience.

Kim HJJ, et al. Early-life stress alters H3K4me1 in VTA to prime stress sensitivity, Neuron (2026).

Part 2

Comment by Dr. Krishna Kumari Challa on August 8, 2026 at 10:22am

Early-life stress leaves a 'scar' inside brain cells

More than half of the world's children are exposed to early-life stress from abuse, household dysfunction such as violence or drug use, or other traumatic experiences. Accumulation of four or more such experiences can trigger much higher risks for long-term mental and physical health challenges in adulthood.

Experiencing severe stress during childhood can make a person more vulnerable to anxiety, depression and other mood disorders when faced with hardships as an adult. Researchers have uncovered how trauma early in life can leave a lasting effect on the brain.
Scientists already knew that stress early in life changes the activity of genes in the brain. In a new study, the research team discovered that this is due to alterations in how brain cells package DNA, leaving the brain's genetic stress response vulnerable to being easily turned on and reducing tolerance to stress.
This new finding reveals a physical scar left by trauma experienced during development inside brain cells, providing scientists with a concrete biological target to develop new treatments and interventions.
The researchers set out to understand how trauma during early development physically changes the brain to make it more sensitive to stress later in life. They focused on a region of the brain called the ventral tegmental area, where brain cells that produce dopamine—a chemical messenger—are responsible for processing important things in the environment, including rewards and adversity.
When these brain cells are activated abnormally, which can happen in response to stress, they disrupt how the brain processes rewards, leaving individuals vulnerable to anxiety and depression.

Within dopamine-producing neurons, the researchers zoomed in on the epigenome, a set of molecular tags that direct the cell's machinery to turn genes on and off, which in turn affects cells' activity.

Inside cells, DNA is coiled like a slinky. The DNA coils are wrapped around histone proteins that help determine how tightly or loosely the coil is wound.

When the genetic slinky is compressed, its genes are turned off. As the DNA slinky stretches and opens, genes are more easily accessible to be turned on.

The researchers found that an enzyme called SETD7 was more abundant in the dopamine neurons of young mice that had experienced stress compared with mice reared in a typical environment. SETD7 helps place a chemical tag—H3K4me1—on the genetic slinky, marking the structure for uncoiling, which in turn makes the cell more reactive to everything going on in the environment.
The researchers then artificially boosted SETD7 in young, stress-free mice. Even without early-life stress, these mice grew up with a stretched-open DNA structure in their dopamine-producing brain cells, making it easier to turn on the genes that respond to stress. Such mice had a lower tolerance for stress in adulthood.

The researchers found that, as adults, mice whose SETD7 levels had been boosted when they were young had more reactive dopamine neurons and more anxious behavior compared with mice with normal levels of SETD7 throughout their lives.
Part 1

Comment by Dr. Krishna Kumari Challa on August 8, 2026 at 10:01am

Mushroom behind 'tiny people' hallucinations identified

People in communities thousands of miles apart have described the same strange experience after eating a mysterious mushroom: vivid visions of tiny humans moving through and interacting with the physical world around them. Known as Lilliputian hallucinations—a reference to the 6-inch-tall inhabitants of "Gulliver's Travels"—the phenomenon has long been thought to stem from cultural influences rather than biology.

A new study suggests otherwise.

Using DNA sequencing, researchers confirmed that a single mushroom species, Lanmaoa asiatica, is responsible for these hallucinations in Southwest China and the northern Philippines.

Three completely independent cultures have reported the same specific type of hallucination, and two cases are attributed to the same DNA-verified mushroom species. That indicates that these bizarre psychological effects aren't cultural manifestations or coincidences—they must have a shared underlying chemical and neurological basis.
People pretty much always report seeing dozens or hundreds of little people, about 3 to 30 centimeters tall (1 to 12 inches), in incredible detail, like they're actually there. About 90% of people describe them as little elves or clowns or other fairy-like figures dressed in colorful clothes.

What's fascinating is they interact with the physical world using the laws of physics that govern us. They're not walking through walls or anything. They're falling off the edge of tables, walking around objects. One person told me that while they were eating soup, the little people were jumping off their spoon into the bowl and swimming around. As they scooped a bite, the little people remained in their mouth.

They also discovered that the mushroom contains none of the psychoactive compounds known to science, including psilocybin. Instead, the findings point to an entirely new hallucinogenic compound that could offer new insights into neurological disease and how the brain shapes perception and consciousness.
However, Lilliputian hallucinations predate this mushroom. There are myths about tiny people in pretty much every culture's folklore. People have also reported these hallucinations from alcohol withdrawal, dementia, macular degeneration and other neurological conditions. So, it seems like this phenomenon is fundamental to how the human mind and brain work.
That's what makes this mushroom different—it reliably produces this effect, whereas those conditions very rarely trigger it.

Colin Domnauer et al, Phylogenomic systematics of Lanmaoa (Boletaceae) reveals cryptic diversity, resolves global evolutionary relationships, and suggests a novel psychoactive lineage, Mycologia (2026). DOI: 10.1080/00275514.2026.2670968

• ‹ Previous
• 1
• 2
• 3
• 4
• 5
• 6
• …
• 1280
• Next ›
• Page